Guihuan S. Qiu - Publications

Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer.

Journal: Clinical lung cancer

Published: December 10, 2024

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial.

Journal: Signal transduction and targeted therapy

Published: August 12, 2024

Biological and clinical characteristics of non-small cell lung cancer non-specific subtype.

Journal: Heliyon

Published: January 15, 2024

A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event.

Journal: Immunopharmacology and immunotoxicology

Published: June 20, 2023

Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 04, 2023

A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study.

Journal: Clinical drug investigation

Published: April 04, 2023

Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched study.

Journal: Thoracic cancer

Published: February 28, 2023

A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancer.

Journal: Cancer medicine

Published: November 22, 2022

Combined small cell lung cancer: current progress and unmet needs.

Journal: American journal of cancer research

Published: November 01, 2022

Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort study.

Journal: Translational lung cancer research

Published: July 19, 2022

Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report.

Journal: Translational lung cancer research

Published: July 19, 2022

Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis.

Journal: Frontiers in immunology

Published: May 04, 2022